9hon MSN
Specialists from the Digestive System Department at Hospital Germans Trias have conducted and published a unique study that ...
Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then ...
Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory ...
6h
Hosted on MSN"I missed out on two or three inches of growth" - Larry Nance Jr. on his late Crohn's Disease diagnosis"I got diagnosed when I was 16," Nance Jr. said, per the Legends of Sport Podcast. "I was a sophomore playing the backup ...
A new study links mitochondrial dysfunction to Crohn’s disease, shifting how scientists approach treatment and opening doors ...
Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) ...
19h
Medical Device Network on MSNBiomerica’s tests for IBD conditions gain CE-marking under EU’s IVDRBiomerica has received CE-marking for its food intolerance tests tailored for ulcerative colitis and Crohn's disease, under ...
A new machine learning model predicts the need for temporary stoma formation after intestinal resection in Crohn’s disease, ...
Though fungi make up a tiny part of the human microbiome, they play an important role in both the prevention and development ...
YESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results